InMed Pharmaceuticals Inc.
INM
Jodie situation report
InMed Pharmaceuticals Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 17 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 1 directly disclosed connection is confirming.
- INM's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if INM's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind INM
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
TAKTakeda Pharmaceutical Company LimitedpartnerNov 6, 2025 ▾
“He currently serves as Head of Global Business Development Operations & Externalization at Takeda Pharmaceuticals, where he has overseen pipeline and commercial divestitures, global alliance management, and integration of corporate transactions.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
INM is currently a Early Follower in the organic co-movement group Healthcare & Credit Tech. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 1 filing-linked name are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for INM; it is not active in the latest market snapshot.